Clinical Trial Update: A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of infliximab (Remicade) in moderate-to-severe Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Crohn Disease | Phase 3 | Status: COMPLETED